Julian S Gangolli insider trades

Open-market stock purchases and sales by Julian S Gangolli, Director at Krystal Biotech, Inc, from SEC Form 4 filings since Nov 28, 2011.

Recent trades

DateStockTradeValue
Sep 14, 2026KRYS Krystal Biotech, IncBought (not open market)—
Sep 14, 2026KRYS Krystal Biotech, IncBought (not open market)—

Companies traded

  • KRYS Krystal Biotech, Inc: 3 sales, last Sep 14, 2026
  • OTLK Outlook Therapeutics, Inc: other filings, last Oct 1, 2025
  • RVNC Revance Therapeutics, Inc: other filings, last Feb 6, 2025
  • GWPH GW Pharmaceuticals plc: 8 sales, last May 10, 2019
  • AGN Allergan Inc: 4 sales, last Mar 17, 2015

Get free alerts when Julian S Gangolli files a new trade →